Dual antiplatelet therapy for reduction in mortality in patients with acute and chronic coronary syndromes

Dual antiplatelet therapy (DAPT) is a foundation of successful coronary artery disease management. DAPT is recommended according to ESC guidelines for 6 months following elective percutaneous coronary intervention and for 12 months following the acute coronary syndrome (ACS). ACS are the most cost-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lesiak, Maciej, Komosa, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802640/
https://www.ncbi.nlm.nih.gov/pubmed/35126547
http://dx.doi.org/10.5114/aic.2021.112082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802640/
https://www.ncbi.nlm.nih.gov/pubmed/35126547
http://dx.doi.org/10.5114/aic.2021.112082

Ejemplares similares